Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 6:37 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 22,004 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Normal Physiology
Interventions: Not listed
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 13 Years to 65 Years
Enrollment: 10,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2035
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Sickle Cell Disease, Sickle Cell Trait
Interventions: Healthy volunteers without SCT, Healthy volunteers with SCT; Other
Lead sponsor: UConn Health; Other
Eligibility: 50 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Cervical Carcinoma
Interventions: HPV Self-Collection, Informational Intervention, Interview, Survey Administration, Receive screening results, Receive recommended steps following abnormal results, Telephone-Based Intervention; Procedure · Other · Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 118 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hepatocellular Carcinoma Recurrent
Interventions: TheraBionic P1; Device
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 22 Years and older
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 6
States / cities: Bay City, Michigan • Detroit, Michigan • Flint, Michigan + 3 more

Conditions: Prostate Adenocarcinoma
Interventions: 68-Ga PSMA11; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 99 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Posttraumatic Headache
Interventions: Cognitive Behavioral Therapy for Posttraumatic Headache, Treatment as Usual, Telemedicine-based Cognitive Behavioral Therapy (TCBT); Behavioral · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 70 Years
Enrollment: 525 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 8
States / cities: Los Angeles, California • Palo Alto, California • Honolulu, Hawaii + 4 more

Conditions: Cervical Cancer, Anal Cancer, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Carcinoma, Uterine Cervical Cancer
Interventions: Radiation Treatment With or Without Chemotherapy, Blood Sample Collection, HPV Genotyping (HPV DNA Test), Testing Archival Tumor Tissue, Physical Exam, Positron Emission Tomography Scan (PET Scan)/ Computed Tomography Scan (CT Scan); Radiation · Other · Diagnostic Test
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Breast Cancer
Interventions: Not listed
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2032
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Hydrocephalus
Interventions: wireless thermal anisotropy measurement device; Device
Lead sponsor: Rhaeos, Inc.; Industry
Eligibility: 6 Years to 80 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Recurrent Bacterial Vaginosis
Interventions: Vaginal microbiome transplant, Oral Metronidazole, Sterile saline; Biological · Drug · Other
Lead sponsor: Douglas Kwon; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-Essential Thrombocytosis Myelofibrosis
Interventions: Ruxolitinib, Tasquinimod; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 1
States / cities: Houston, Texas

Conditions: HIV Infections, Substance Use, Trauma, Medication Adherence
Interventions: Acceptance and Commitment Therapy (ACT), Body weight circuit training, Empathetic social support, Control - list of resources; Behavioral · Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older · Female only
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: San Diego, California

Conditions: Stress
Interventions: Serial bedside video call communication; Other
Lead sponsor: Cook County Health; Government
Eligibility: 7 Days to 60 Days
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Myasthenia Gravis, Neuromuscular Disease, Neuromuscular Manifestations
Interventions: Social media recruitment, Self-Assessment, Follow-up; Behavioral
Lead sponsor: ZS Associates; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Liver Transplantation, Immune Tolerance, Immune Tolerance/Drug Effects, Graft Survival, Hematopoietic Stem Cell, Chimerism, Immunosuppression After Liver Transplantation, Immunosuppression Disorders, End Stage Liver Disease
Interventions: Donor Hematopoietic Stem and Progenitor Cell Infusion; Biological
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Wound Healing and Prevention, Oral Inflammation, Photobiomodulation, Post-operative Pain Management, Tooth Extraction Site Healing
Interventions: Low-level laser therapy; Other
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Depression
Interventions: Neurostimulation; Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: PTSD, Substance Use Disorders
Interventions: COPEWeb online training, COPE In Person; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Neuroendocrine Carcinoma Metastatic, Pancreatic Tumors
Interventions: [18F]FluorThanatrace; Drug
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Nasal Obstruction
Interventions: Nasal Plug; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 330 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Non-small Cell Lung Cancer Stage III, Non-small Cell Lung Cancer Stage IV, Non-small Cell Lung Cancer, Lung Cancer
Interventions: Pulmonary Rehabilitation (PR), No intervention: Usual care; Behavioral · Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cardiac Arrythmias, Left Atrial Appendage Closure
Interventions: Transseptal procedure with Agilis RF TSP System.; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 3
States / cities: Jonesboro, Arkansas • San Francisco, California • Kansas City, Missouri

Conditions: Spinal Cord Injuries, Spinal Cord Injury Cervical
Interventions: Bidirectional Neural Bypass System; Device
Lead sponsor: Chad Bouton; Other
Eligibility: 22 Years to 65 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Schizophrenia
Interventions: MDMA 40mg, MDMA 80mg, MDMA 120mg; Drug
Lead sponsor: Anya Bershad, MD, PhD; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Perception, Sensation, Cognition and Action in Humans

Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait

A Community Based Intervention to Improve Cervical Cancer Screening Among Women in the Hispanic and East African Immigrant Community

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma

PSMA PET Response Guided SabR in High Risk Pca

Multisite Advancement of Research on Chronic Posttraumatic Headache

Detecting HPV DNA in Anal and Cervical Cancers

Intra-Operative Radiation Registry

Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device

Vaginal Microbiota Transplant

Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)

Women Focused Encounters for Resilience Independence Strength and Eudaimonia

Impact of Serial Bedside Video Calls on Stress Level in Parents of Infants Admitted to NICU

Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment

Immune Tolerance Induction After Liver Transplantation

Impact of Nd:YAG Laser Photobiostimulation on Healing of Gingiva

Brain Stimulation and Decision-making

COPEWeb Training for Providers

FTT PET/CT in Pancreatic Neuroendocrine Tumors

Nasal Obstruction and Olfactory Losses

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Agilis RF TSP Early Feasibility Study

Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System

Tolerability of MDMA in Schizophrenia